Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAB-Paclitaxel and Carboplatin in Gastrointestinal Neuroendocrine Carcinomas (NABNEC)
NCT02215447Phase 2Unknown
- Sponsor
- Barwon Health
- Start
- May 2015
- Primary completion
- Nov 2018
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in gastrointestinal neuroendocrine carcinoma (GI-NEC), sponsored by Barwon Health. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
gastrointestinal neuroendocrine carcinoma (GI-NEC)
Beyond the preview
Go deeper on NCT02215447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215447.